CIK: 1340097 - Address: 750 Lexington Avenue 30Th Floor, New York, NY 10022
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
10/16/23 17:46
10/12/23
SRRKScholar Rock Holding CorpDEHealthBioPrdBiological Products, (No DiagInvus Public Equities, L.P.NYTP15,0876.8602,2002411,259D
5/2/23 21:00
4/28/23
SRRKScholar Rock Holding CorpDEHealthBioPrdBiological Products, (No DiagInvus Public Equities, L.P.NYTP2036.4303209,060D
2/23/23 18:23
2/21/23
GLYCGlycomimetics IncDEHealthDrugPharmaceutical PreparationsInvus Public Equities, L.P.NYTP.m7121.78040058,489D
2/17/23 17:29
2/15/23
GLYCGlycomimetics IncDEHealthDrugPharmaceutical PreparationsInvus Public Equities, L.P.NYTP.m3,0282.0001,515238,089D
2/13/23 17:45
2/9/23
GLYCGlycomimetics IncDEHealthDrugPharmaceutical PreparationsInvus Public Equities, L.P.NYTP373.2401106,574D
1/11/23 20:30
1/9/23
SRRKScholar Rock Holding CorpDEHealthBioPrdBiological Products, (No DiagInvus Public Equities, L.P.NYTS-109.480-109,028D
1/9/23 17:22
1/5/23
SRRKScholar Rock Holding CorpDEHealthBioPrdBiological Products, (No DiagInvus Public Equities, L.P.NYTP4559.3304919,029D
10/27/22 16:36
10/25/22
SRRKScholar Rock Holding CorpDEHealthBioPrdBiological Products, (No DiagInvus Public Equities, L.P.NYTP1,0478.04013018,980D
10/7/22 16:30
10/3/22
SRRKScholar Rock Holding CorpDEHealthBioPrdBiological Products, (No DiagInvus Public Equities, L.P.NYTP.m7607.60010018,850D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact